Seehofer D - Search Results

1

Initial liver graft function is a reliable predictor of tacrolimus trough levels during the first post-transplant week.

Lock JF, Malinowski M, Schwabauer E, Martus P, Pratschke J, Seehofer D, Puhl G, Neuhaus P, Stockmann M. Lock JF, et al. Among authors: seehofer d. Clin Transplant. 2011 May-Jun;25(3):436-43. doi: 10.1111/j.1399-0012.2010.01264.x. Epub 2010 May 10. Clin Transplant. 2011. PMID: 20482563

2

Intravital microscopy for evaluation of early xenograft viability of isolated perfused rat livers.

Seehofer D, Baatz H, Thiery J, Hammer C. Seehofer D, et al. Transplant Proc. 1996 Apr;28(2):724-5. Transplant Proc. 1996. PMID: 8623365 No abstract available.

3

Fluorescence videomicroscopic assessment of xenogeneic microcirculation and impact of antibody removal by immunoadsorption.

Seehofer D, Baatz H, Thiery J, Müller-Hocker J, Müller-Derlich J, Hammer C. Seehofer D, et al. Transplantation. 1997 Feb 15;63(3):460-5. doi: 10.1097/00007890-199702150-00022. Transplantation. 1997. PMID: 9039940

4

Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation.

Rayes N, Seehofer D, Bechstein WO, Müller AR, Berg T, Neuhaus R, Neuhaus P. Rayes N, et al. Among authors: seehofer d. Clin Transplant. 1999 Dec;13(6):447-52. doi: 10.1034/j.1399-0012.1999.130602.x. Clin Transplant. 1999. PMID: 10617232 Clinical Trial.

5

Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report.

Seehofer D, Rayes N, Berg T, Neuhaus R, Hopf U, Müller AR, Bechstein WO, Neuhaus P. Seehofer D, et al. Transplantation. 2000 Apr 27;69(8):1739-42. doi: 10.1097/00007890-200004270-00039. Transplantation. 2000. PMID: 10836394

6

Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.

Seehofer D, Rayes N, Berg T, Neuhaus R, Müller AR, Hopf U, Bechstein WO, Neuhaus P. Seehofer D, et al. Transpl Int. 2000;13(4):290-6. doi: 10.1007/s001470050704. Transpl Int. 2000. PMID: 10959482 Clinical Trial.

7

L-arginine application improves graft morphology and mucosal barrier function after small bowel transplantation.

Mueller AR, Platz KP, Schirmeier A, Nüssler NC, Seehofer D, Schmitz V, Nüssler AK, Radke C, Neuhaus P. Mueller AR, et al. Among authors: seehofer d. Transplant Proc. 2000 Sep;32(6):1275-7. doi: 10.1016/s0041-1345(00)01222-7. Transplant Proc. 2000. PMID: 10995944 No abstract available.

8

Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.

Seehofer D, Rayes N, Neuhaus R, Berg T, Müller AR, Bechstein WO, Neuhaus P. Seehofer D, et al. Transpl Int. 2000;13 Suppl 1:S359-62. doi: 10.1007/s001470050361. Transpl Int. 2000. PMID: 11112032

9

Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.

Rayes N, Seehofer D, Hopf U, Neuhaus R, Naumann U, Bechstein WO, Neuhaus P. Rayes N, et al. Among authors: seehofer d. Transplantation. 2001 Jan 15;71(1):96-101. doi: 10.1097/00007890-200101150-00016. Transplantation. 2001. PMID: 11211203

10

Is preemptive therapy for CMV infection following liver transplantation superior to symptom-triggered treatment?

Rayes N, Seehofer D, Schmidt CA, Müller AR, Steinmüller T, Bechstein WO, Neuhaus P. Rayes N, et al. Among authors: seehofer d. Transplant Proc. 2001 Feb-Mar;33(1-2):1804. doi: 10.1016/s0041-1345(00)02688-9. Transplant Proc. 2001. PMID: 11267520 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results